Arcturus Therapeutics

Arcturus Therapeutics Focuses on RNA Medicines for Rare Diseases. Arcturus has developed a novel, potent, and safe RNA Therapeutics platform called LUNARTM, a proprietary lipid delivery system for RNA medicines, including small interfering RNA, messenger RNA, antisense, and microRNA oligomers. The company owns Unlocked Nucleic Acid (UNA) chemistry technology and a patent portfolio (32 patents granted by the USPTO), enabling targeting of any gene in the human genome.